ArticleFrontiers in neurology2025
Epilepsy in children: quality of life and disease control.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Elevated serum plasminogen activator inhibitor-1 is associated with seizure burden, drug resistance, and neuroinflammatory markers in pediatric epilepsy.Frontiers in pediatrics · 2026Article
- Determinants of health-related quality of life in pediatric epilepsy: the impact of treatment tolerability and epilepsy type.Frontiers in neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Childhood epilepsy negatively affects health, quality of life (QoL), and character development. Methods: A cross-sectional online survey was conducted among pediatric epilepsy patients in Jordan. Candidates were identified through a hospital database. The shortened Quality of Life in Childhood Epilepsy Questionnaire (QOLCE-55) assessed QoL. Disease control was defined as seizure-free for 1 year. Clinical characteristics, QoL, disease control, and their determinants among pediatric epilepsy patients in Jordan were assessed. Results: A total of 178 patients participated. The mean health-related QoL (HRQoL) score was 50.74 ± 22.54, highest in emotional wellbeing (60.75 ± 19.40) and lowest in physical functioning (44.75 ± 24.06). Higher HRQoL was significantly associated with older age at diagnosis (β = 1.668, Conclusion: Epilepsy significantly reduces QoL in children. Better QoL and seizure control were linked to older age, absence of comorbidities, fewer seizures, and reduced medication use. Caregiver support and minimizing polytherapy may enhance both QoL and disease control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.